carnosine has been researched along with Cirrhosis, Liver in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Du, Q; Li, Y; Lu, M; Lu, X; Ye, J; Zhang, Z; Zhou, J; Zhu, L | 1 |
| Asama, T; Chisato, N; Ebisawa, Y; Furukawa, H; Imai, K; Karasaki, H; Kono, T; Okayama, T; Yoneda, M | 1 |
| Deguchi, A; Himoto, T; Hosomi, N; Kinekawa, F; Kuriyama, S; Kurokochi, K; Masaki, T; Matsuki, M; Nakai, S; Senda, S; Watanabe, S; Yachida, M | 1 |
| Kumagai, N; Morinaga, S; Sugino, H; Takeuchi, O; Toda, K; Tsuchimoto, K; Tsunematsu, S; Watanabe, S | 1 |
| Jiang, LN; Li, X; Li, Y; Lu, FM; Zhao, JM; Zhu, L | 1 |
| Abdelazim, SA; Ali, SA; Darwish, HA; Kadry, MO; Rizk, MZ | 1 |
| Alsheblak, MM; El-Karef, A; El-Shishtawy, MM; Elsherbiny, NM | 1 |
| Abasvali, M; Abdoli, N; Asadi, B; Azarpira, N; Heidari, R; Jafari, F; Jamshidzadeh, A; Latifpour, Z; Mardani, E; Mousavi, S; Najibi, A; Ommati, MM; Saeedi, A; Yeganeh, Y; Zarei, A; Zarei, M | 1 |
| Aydin, AF; Doğru-Abbasoğlu, S; Güllüoğlu, M; Koçak-Toker, N; Küskü-Kiraz, Z; Uysal, M | 1 |
| Fischer, C; Gotthardt, D; Hoffmann, GF; Jakobs, C; Jansen, EE; Janssen, B; Köppel, H; Peters, V; Riedl, E; Wedel, J; Yard, BA; Zschocke, J | 1 |
| Endoh, A; Goto, T; Kataoka, E; Mikami, K; Miura, K; Odashima, M; Ohshima, S; Otaka, M; Sato, M; Sato, W; Segawa, D; Shibuya, T; Takeuchi, S; Watanabe, D; Watanabe, S; Yoneyama, K; Yoshino, R | 1 |
11 other study(ies) available for carnosine and Cirrhosis, Liver
| Article | Year |
|---|---|
Polaprezinc inhibits liver fibrosis and proliferation in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Carnosine; Cell Line; Cell Proliferation; Cluster Analysis; Colony-Forming Units Assay; Gene Expression Profiling; Hep G2 Cells; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Liver Neoplasms; Organometallic Compounds; Zinc Compounds | 2017 |
Polaprezinc prevents ongoing thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Antioxidants; Carnosine; Liver Cirrhosis; Male; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Thioacetamide; Zinc; Zinc Compounds | 2012 |
Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Carnosine; Collagen Type IV; Copper; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Iron; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Organometallic Compounds; Platelet Count; Serum Albumin; Time Factors; Zinc; Zinc Compounds | 2007 |
Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Carnosine; Choline Deficiency; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Animal; Fatty Liver; Gene Expression Regulation; Hepatic Stellate Cells; Lipid Peroxidation; Liver; Liver Cirrhosis; Male; Matrix Metalloproteinase 2; Methionine; Mice; Mice, Inbred C57BL; Organometallic Compounds; RNA, Messenger; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha; Zinc Compounds | 2008 |
[A preliminary discussion on carnosine dipeptidase 1 as a potential novel biomarker for the diagnostic and prognostic evaluation of hepatocellular carcinoma].
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Carnosine; Humans; Liver Cirrhosis; Liver Neoplasms; Prognosis; ROC Curve | 2023 |
Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury.
Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Antioxidants; Aspartate Aminotransferases; Carnosine; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Glutathione Transferase; Hep G2 Cells; Humans; Liver Cirrhosis; Male; Mice; Nitrates; Nitrites; Smad2 Protein; Titanium; Transforming Growth Factor beta; Ubiquinone; Vascular Endothelial Growth Factor A; Vitamin E | 2015 |
Protective effects of L-carnosine on CCl4 -induced hepatic injury in rats.
Topics: Actins; Animals; Biomarkers; Carbon Tetrachloride; Carnosine; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Gene Expression; Inflammation; Liver Cirrhosis; Liver Function Tests; Male; Models, Biological; NF-E2-Related Factor 2; Nitric Oxide; Oxidation-Reduction; Oxidative Stress; Protective Agents; Rats; Superoxide Dismutase | 2016 |
Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
Topics: Animals; Carnosine; Hyperammonemia; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley | 2017 |
Effect of carnosine against thioacetamide-induced liver cirrhosis in rat.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carnosine; Female; Glutathione; Glutathione Peroxidase; Humans; Liver; Liver Cirrhosis; Malondialdehyde; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Thioacetamide | 2010 |
Anserine inhibits carnosine degradation but in human serum carnosinase (CN1) is not correlated with histidine dipeptide concentration.
Topics: Adult; Anserine; Carnosine; Dipeptidases; Female; Histidine; Humans; Liver Cirrhosis; Male; Middle Aged; Young Adult | 2011 |
Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72.
Topics: Animals; Bile Ducts; Blotting, Western; Carnosine; Disease Models, Animal; Dose-Response Relationship, Drug; Gastric Mucosa; HSP72 Heat-Shock Proteins; Hypertension, Portal; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Zinc Sulfate | 2006 |